- Home
- DYNC vs EVMN Comparison
DYNC vs EVMN Comparison
Compare DYNC & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
SELL
BUY
Current Price
$5.17
Company Overview
Basic Information| Metric | DYNC | EVMN |
|---|---|---|
| Founded | 2024 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.8M | 241.3M |
| IPO Year | 2024 | 2025 |
Fundamental Metrics
Financial Performance| Metric | DYNC | EVMN |
|---|---|---|
| Price | $10.87 | $5.17 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $22.33 |
| AVG Volume (30 Days) | 46.9K | ★ 808.3K |
| Earning Date | 11-05-2026 | 11-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 75.23 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 85.71 |
| 52 Week Low | $10.76 | $5.09 |
| 52 Week High | $10.99 | $33.20 |
Technical Indicators
Market Signals| Indicator | DYNC | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 46.48 | 20.22 |
| Support Level | $10.84 | N/A |
| Resistance Level | $10.95 | $13.35 |
| Average True Range (ATR) | 0.03 | 0.39 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 33.33 | 3.53 |
Price Performance
Historical Comparison DYNC
EVMN
About DYNC Dynamix Corporation Class A Ordinary Shares
Dynamix Corp is a blank check company.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.